BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin SH, Shiang JC, Huang CC, Yang SS, Hsu YJ, Cheng CJ. Phenotype and genotype analysis in Chinese patients with Gitelman's syndrome. J Clin Endocrinol Metab 2005;90:2500-7. [PMID: 15687331 DOI: 10.1210/jc.2004-1905] [Cited by in Crossref: 71] [Cited by in F6Publishing: 59] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Yang SS, Lo YF, Yu IS, Lin SW, Chang TH, Hsu YJ, Chao TK, Sytwu HK, Uchida S, Sasaki S, Lin SH. Generation and analysis of the thiazide-sensitive Na+ -Cl- cotransporter (Ncc/Slc12a3) Ser707X knockin mouse as a model of Gitelman syndrome. Hum Mutat 2010;31:1304-15. [PMID: 20848653 DOI: 10.1002/humu.21364] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
2 Zhang L, Huang K, Wang S, Fu H, Wang J, Shen H, Lu Z, Chen J, Bao Y, Feng C, Dong G, Mao J. Clinical and Genetic Features in 31 Serial Chinese Children With Gitelman Syndrome. Front Pediatr 2021;9:544925. [PMID: 33996672 DOI: 10.3389/fped.2021.544925] [Reference Citation Analysis]
3 Tutakhel OAZ, Bianchi F, Smits DA, Bindels RJM, Hoenderop JGJ, van der Wijst J. Dominant functional role of the novel phosphorylation site S811 in the human renal NaCl cotransporter. FASEB J 2018;32:4482-93. [PMID: 29547703 DOI: 10.1096/fj.201701047R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Nozu K, Nozu Y, Nakanishi K, Konomoto T, Horinouchi T, Shono A, Morisada N, Minamikawa S, Yamamura T, Fujimura J, Nakanishi K, Ninchoji T, Kaito H, Morioka I, Taniguchi-Ikeda M, Vorechovsky I, Iijima K. Cryptic exon activation in SLC12A3 in Gitelman syndrome. J Hum Genet 2017;62:335-7. [PMID: 27784896 DOI: 10.1038/jhg.2016.129] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
5 Nozu K, Iijima K, Nozu Y, Ikegami E, Imai T, Fu XJ, Kaito H, Nakanishi K, Yoshikawa N, Matsuo M. A deep intronic mutation in the SLC12A3 gene leads to Gitelman syndrome. Pediatr Res 2009;66:590-3. [PMID: 19668106 DOI: 10.1203/PDR.0b013e3181b9b4d3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
6 Nakamura A, Shimizu C, Nagai S, Yoshida M, Aoki K, Kondo T, Miyoshi H, Wada N, Tajima T, Terauchi Y, Yoshioka N, Koike T. Problems in diagnosing atypical Gitelman's syndrome presenting with normomagnesaemia. Clin Endocrinol (Oxf) 2010;72:272-6. [PMID: 19508680 DOI: 10.1111/j.1365-2265.2009.03649.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
7 Chen SY, Jie N. Gitelman syndrome: A case report. World J Clin Cases 2022; 10(17): 5893-5898 [DOI: 10.12998/wjcc.v10.i17.5893] [Reference Citation Analysis]
8 McCormick JA, Ellison DH. Distal convoluted tubule. Compr Physiol 2015;5:45-98. [PMID: 25589264 DOI: 10.1002/cphy.c140002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 36] [Article Influence: 1.7] [Reference Citation Analysis]
9 Yang SS, Fang YW, Tseng MH, Chu PY, Yu IS, Wu HC, Lin SW, Chau T, Uchida S, Sasaki S, Lin YF, Sytwu HK, Lin SH. Phosphorylation regulates NCC stability and transporter activity in vivo. J Am Soc Nephrol 2013;24:1587-97. [PMID: 23833262 DOI: 10.1681/ASN.2012070742] [Cited by in Crossref: 34] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
10 Zhang JH, Ruan DD, Hu YN, Ruan XL, Zhu YB, Yang X, Wu JB, Lin XF, Luo JW, Tang FQ. Review and Analysis of Two Gitelman Syndrome Pedigrees Complicated with Proteinuria or Hashimoto's Thyroiditis Caused by Compound Heterozygous SLC12A3 Mutations. Biomed Res Int 2021;2021:9973161. [PMID: 34046503 DOI: 10.1155/2021/9973161] [Reference Citation Analysis]
11 Shao L, Ren H, Wang W, Zhang W, Feng X, Li X, Chen N. Novel SLC12A3 mutations in Chinese patients with Gitelman's syndrome. Nephron Physiol 2008;108:p29-36. [PMID: 18287808 DOI: 10.1159/000117815] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
12 Gómez CJB, Gil-Peña H, Álvarez FAO, Rodríguez FS. Outcome of primary tubular tubulopathies diagnosed in pediatric age. Nefrologia 2021;41:182-90. [PMID: 34167771 DOI: 10.1016/j.nefroe.2020.07.001] [Reference Citation Analysis]
13 Lee JW, Lee J, Heo NJ, Cheong HI, Han JS. Mutations in SLC12A3 and CLCNKB and Their Correlation with Clinical Phenotype in Patients with Gitelman and Gitelman-like Syndrome. J Korean Med Sci. 2016;31:47-54. [PMID: 26770037 DOI: 10.3346/jkms.2016.31.1.47] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 2.9] [Reference Citation Analysis]
14 Dimke H. Exploring the intricate regulatory network controlling the thiazide-sensitive NaCl cotransporter (NCC). Pflugers Arch 2011;462:767-77. [PMID: 21927811 DOI: 10.1007/s00424-011-1027-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
15 Alessi DR, Zhang J, Khanna A, Hochdörfer T, Shang Y, Kahle KT. The WNK-SPAK/OSR1 pathway: master regulator of cation-chloride cotransporters. Sci Signal 2014;7:re3. [PMID: 25028718 DOI: 10.1126/scisignal.2005365] [Cited by in Crossref: 175] [Cited by in F6Publishing: 149] [Article Influence: 21.9] [Reference Citation Analysis]
16 van der Merwe PD, Rensburg MA, Haylett WL, Bardien S, Davids MR. Gitelman syndrome in a South African family presenting with hypokalaemia and unusual food cravings. BMC Nephrol. 2017;18:38. [PMID: 28125972 DOI: 10.1186/s12882-017-0455-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
17 Kondo A, Nagano C, Ishiko S, Omori T, Aoto Y, Rossanti R, Sakakibara N, Horinouchi T, Yamamura T, Nagai S, Okada E, Shima Y, Nakanishi K, Ninchoji T, Kaito H, Takeda H, Nagase H, Morisada N, Iijima K, Nozu K. Examination of the predicted prevalence of Gitelman syndrome by ethnicity based on genome databases. Sci Rep 2021;11:16099. [PMID: 34373523 DOI: 10.1038/s41598-021-95521-6] [Reference Citation Analysis]
18 Glover M, O'shaughnessy KM. SPAK and WNK kinases: a new target for blood pressure treatment? Curr Opin Nephrol Hypertens 2011;20:16-22. [PMID: 21088576 DOI: 10.1097/MNH.0b013e32834132bc] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
19 Godefroid N, Riveira-munoz E, Saint-martin C, Nassogne M, Dahan K, Devuyst O. A Novel Splicing Mutation in SLC12A3 Associated With Gitelman Syndrome and Idiopathic Intracranial Hypertension. American Journal of Kidney Diseases 2006;48:e73-9. [DOI: 10.1053/j.ajkd.2006.08.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
20 Zhong F, Ying H, Jia W, Zhou X, Zhang H, Guan Q, Xu J, Fang L, Zhao J, Xu C. Characteristics and Follow-Up of 13 pedigrees with Gitelman syndrome. J Endocrinol Invest 2019;42:653-65. [PMID: 30413979 DOI: 10.1007/s40618-018-0966-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Cheng CJ, Shiang JC, Hsu YJ, Yang SS, Lin SH. Hypocalciuria in patients with Gitelman syndrome: role of blood volume. Am J Kidney Dis 2007;49:693-700. [PMID: 17472852 DOI: 10.1053/j.ajkd.2007.02.267] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
22 Qin YZ, Liu YM, Wang Y, You C, Li LN, Zhou XY, Lv WM, Hong SH, Xiao LX. Novel compound heterozygous mutation of SLC12A3 in Gitelman syndrome co-existent with hyperthyroidism: A case report and literature review. World J Clin Cases 2022; 10(21): 7483-7494 [DOI: 10.12998/wjcc.v10.i21.7483] [Reference Citation Analysis]
23 Zhang Y, Zhang F, Chen D, Lü Q, Tang L, Yang C, Lei M, Tong N. A novel homozygous mutation in the solute carrier family 12 member 3 gene in a Chinese family with Gitelman syndrome. Braz J Med Biol Res 2016;49:e5261. [PMID: 27783806 DOI: 10.1590/1414-431X20165261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
24 Glover M, O'Shaughnessy KM. Molecular insights from dysregulation of the thiazide-sensitive WNK/SPAK/NCC pathway in the kidney: Gordon syndrome and thiazide-induced hyponatraemia. Clin Exp Pharmacol Physiol 2013;40:876-84. [PMID: 23683032 DOI: 10.1111/1440-1681.12115] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
25 Brugnara M, Gaudino R, Tedeschi S, Syrèn ML, Perrotta S, Maines E, Zaffanello M. Type III Bartter-like syndrome in an infant boy with Gitelman syndrome and autosomal dominant familial neurohypophyseal diabetes insipidus. J Pediatr Endocrinol Metab 2014;27:971-5. [PMID: 24825090 DOI: 10.1515/jpem-2014-0052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
26 Glover M, Clayton J. Thiazide-induced hyponatraemia: epidemiology and clues to pathogenesis. Cardiovasc Ther 2012;30:e219-26. [PMID: 21884020 DOI: 10.1111/j.1755-5922.2011.00286.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
27 Ariceta G, Rodríguez-soriano J. Inherited Renal Tubulopathies Associated With Metabolic Alkalosis: Effects on Blood Pressure. Seminars in Nephrology 2006;26:422-33. [DOI: 10.1016/j.semnephrol.2006.10.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
28 Rossanti R, Horinouchi T, Sakakibara N, Yamamura T, Nagano C, Ishiko S, Aoto Y, Kondo A, Nagai S, Awano H, Nagase H, Matsuo M, Iijima K, Nozu K. Detecting pathogenic deep intronic variants in Gitelman syndrome. Am J Med Genet A 2022. [PMID: 35785516 DOI: 10.1002/ajmg.a.62885] [Reference Citation Analysis]
29 Liu Z, Wang S, Zhang R, Wang C, Lu J, Shao L. A novel compound heterozygous variant of the SLC12A3 gene in Gitelman syndrome with diabetes and the choices of the appropriate hypoglycemic drugs: a case report. BMC Med Genomics 2021;14:198. [PMID: 34348722 DOI: 10.1186/s12920-021-01047-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Hsu Y, Yang S, Chu N, Sytwu H, Cheng C, Lin S. Heterozygous mutations of the sodium chloride cotransporter in Chinese children: prevalence and association with blood pressure. Nephrology Dialysis Transplantation 2008;24:1170-5. [DOI: 10.1093/ndt/gfn619] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
31 Wardak H, Tutakhel OAZ, Van Der Wijst J. Role of the alternative splice variant of NCC in blood pressure control. Channels (Austin) 2018;12:346-55. [PMID: 30264650 DOI: 10.1080/19336950.2018.1528820] [Reference Citation Analysis]
32 Santos F, Gil-peña H, Blázquez C, Coto E. Gitelman syndrome: a review of clinical features, genetic diagnosis and therapeutic management. Expert Opinion on Orphan Drugs 2016;4:1005-9. [DOI: 10.1080/21678707.2016.1223542] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
33 Riveira-Munoz E, Chang Q, Godefroid N, Hoenderop JG, Bindels RJ, Dahan K, Devuyst O; Belgian Network for Study of Gitelman Syndrome. Transcriptional and functional analyses of SLC12A3 mutations: new clues for the pathogenesis of Gitelman syndrome. J Am Soc Nephrol. 2007;18:1271-1283. [PMID: 17329572 DOI: 10.1681/asn.2006101095] [Cited by in Crossref: 100] [Cited by in F6Publishing: 38] [Article Influence: 6.7] [Reference Citation Analysis]
34 Yang SS, Lo YF, Wu CC, Lin SW, Yeh CJ, Chu P, Sytwu HK, Uchida S, Sasaki S, Lin SH. SPAK-knockout mice manifest Gitelman syndrome and impaired vasoconstriction. J Am Soc Nephrol 2010;21:1868-77. [PMID: 20813865 DOI: 10.1681/ASN.2009121295] [Cited by in Crossref: 201] [Cited by in F6Publishing: 131] [Article Influence: 16.8] [Reference Citation Analysis]
35 de La Faille R, Vallet M, Venisse A, Nau V, Collet-Gaudillat C, Houillier P, Jeunemaitre X, Vargas-Poussou R. A pseudo-dominant form of Gitelman's syndrome. NDT Plus 2011;4:386-9. [PMID: 25984200 DOI: 10.1093/ndtplus/sfr094] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
36 Sung CC, Chen YS, Lin SH. Family paralysis. Lancet 2011;377:352. [PMID: 21256383 DOI: 10.1016/S0140-6736(10)61356-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
37 Glover M, Zuber AM, O'Shaughnessy KM. Hypertension, dietary salt intake, and the role of the thiazide-sensitive sodium chloride transporter NCCT. Cardiovasc Ther 2011;29:68-76. [PMID: 21167012 DOI: 10.1111/j.1755-5922.2010.00180.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
38 Zhang J, Siew K, Macartney T, O'Shaughnessy KM, Alessi DR. Critical role of the SPAK protein kinase CCT domain in controlling blood pressure. Hum Mol Genet 2015;24:4545-58. [PMID: 25994507 DOI: 10.1093/hmg/ddv185] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
39 Chu PY, Cheng CJ, Wu YC, Fang YW, Chau T, Uchida S, Sasaki S, Yang SS, Lin SH. SPAK deficiency corrects pseudohypoaldosteronism II caused by WNK4 mutation. PLoS One 2013;8:e72969. [PMID: 24039833 DOI: 10.1371/journal.pone.0072969] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
40 Yan MT, Yang SS, Tseng MH, Cheng CJ, Tsai JD, Sung CC, Hsu YJ, Lin SH. Allele-specific RT-PCR for the rapid detection of recurrent SLC12A3 mutations for Gitelman syndrome. NPJ Genom Med 2021;6:68. [PMID: 34389731 DOI: 10.1038/s41525-021-00230-8] [Reference Citation Analysis]
41 Vargas-Poussou R, Dahan K, Kahila D, Venisse A, Riveira-Munoz E, Debaix H, Grisart B, Bridoux F, Unwin R, Moulin B, Haymann JP, Vantyghem MC, Rigothier C, Dussol B, Godin M, Nivet H, Dubourg L, Tack I, Gimenez-Roqueplo AP, Houillier P, Blanchard A, Devuyst O, Jeunemaitre X. Spectrum of mutations in Gitelman syndrome. J Am Soc Nephrol. 2011;22:693-703. [PMID: 21415153 DOI: 10.1681/asn.2010090907] [Cited by in Crossref: 122] [Cited by in F6Publishing: 53] [Article Influence: 11.1] [Reference Citation Analysis]
42 Oba T, Kobayashi S, Nakamura Y, Nagao M, Nozu K, Fukuda I, Iijima K, Sugihara H. A Case of Gitelman Syndrome that Was Difficult to Distinguish from Hypokalemic Periodic Paralysis Caused by Graves' Disease. J Nippon Med Sch 2019;86:301-6. [PMID: 31105122 DOI: 10.1272/jnms.JNMS.2019_86-505] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Balavoine AS, Bataille P, Vanhille P, Azar R, Noël C, Asseman P, Soudan B, Wémeau JL, Vantyghem MC. Phenotype-genotype correlation and follow-up in adult patients with hypokalaemia of renal origin suggesting Gitelman syndrome. Eur J Endocrinol 2011;165:665-73. [PMID: 21753071 DOI: 10.1530/EJE-11-0224] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
44 Zhang J, Karimy JK, Delpire E, Kahle KT. Pharmacological targeting of SPAK kinase in disorders of impaired epithelial transport. Expert Opin Ther Targets 2017;21:795-804. [PMID: 28679296 DOI: 10.1080/14728222.2017.1351949] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
45 Jiang L, Chen C, Yuan T, Qin Y, Hu M, Li X, Xing X, Lee X, Nie M, Chen L. Clinical severity of Gitelman syndrome determined by serum magnesium. Am J Nephrol 2014;39:357-66. [PMID: 24776766 DOI: 10.1159/000360773] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
46 Qin L, Shao L, Ren H, Wang W, Pan X, Zhang W, Wang Z, Shen P, Chen N. Identification of five novel variants in the thiazide-sensitive NaCl co-transporter gene in Chinese patients with Gitelman syndrome. Nephrology (Carlton) 2009;14:52-8. [PMID: 19207868 DOI: 10.1111/j.1440-1797.2008.01042.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
47 Lin SH, Yang SS, Chau T. A practical approach to genetic hypokalemia. Electrolyte Blood Press. 2010;8:38-50. [PMID: 21468196 DOI: 10.5049/ebp.2010.8.1.38] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
48 Kumagai H, Matsumoto S, Nozu K. Hypokalemic rhabdomyolysis in a child with Gitelman's syndrome. Pediatr Nephrol. 2010;25:953-955. [PMID: 20072789 DOI: 10.1007/s00467-009-1412-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
49 Lo YF, Nozu K, Iijima K, Morishita T, Huang CC, Yang SS, Sytwu HK, Fang YW, Tseng MH, Lin SH. Recurrent deep intronic mutations in the SLC12A3 gene responsible for Gitelman's syndrome. Clin J Am Soc Nephrol 2011;6:630-9. [PMID: 21051746 DOI: 10.2215/CJN.06730810] [Cited by in Crossref: 41] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
50 van der Wijst J, Belge H, Bindels RJM, Devuyst O. Learning Physiology From Inherited Kidney Disorders. Physiol Rev 2019;99:1575-653. [PMID: 31215303 DOI: 10.1152/physrev.00008.2018] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
51 Richardson C, Sakamoto K, de los Heros P, Deak M, Campbell DG, Prescott AR, Alessi DR. Regulation of the NKCC2 ion cotransporter by SPAK-OSR1-dependent and -independent pathways. J Cell Sci 2011;124:789-800. [PMID: 21321328 DOI: 10.1242/jcs.077230] [Cited by in Crossref: 113] [Cited by in F6Publishing: 111] [Article Influence: 10.3] [Reference Citation Analysis]
52 Aoi N, Nakayama T, Tahira Y, Haketa A, Yabuki M, Sekiyama T, Nakane C, Mano H, Kawachi H, Sato N, Soma M, Matsumoto K. Two novel genotypes of the thiazide-sensitive Na-Cl cotransporter (SLC12A3) gene in patients with Gitelman's syndrome. Endocrine 2007;31:149-53. [PMID: 17873326 DOI: 10.1007/s12020-007-0024-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
53 Kortenoeven MLA, Pedersen NB, Rosenbaek LL, Fenton RA. Vasopressin regulation of sodium transport in the distal nephron and collecting duct. American Journal of Physiology-Renal Physiology 2015;309:F280-99. [DOI: 10.1152/ajprenal.00093.2015] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 5.3] [Reference Citation Analysis]
54 Li X, Chen R, Chen M. Clinical Characteristics and Gene Mutation Analysis of the Chinese Han Population with Gitelman Syndrome: 3 Case Reports and a Literature Review. Case Rep Med 2020;2020:6263721. [PMID: 33163079 DOI: 10.1155/2020/6263721] [Reference Citation Analysis]
55 Glover M, Zuber AM, O'Shaughnessy KM. Renal and brain isoforms of WNK3 have opposite effects on NCCT expression. J Am Soc Nephrol 2009;20:1314-22. [PMID: 19470686 DOI: 10.1681/ASN.2008050542] [Cited by in Crossref: 43] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
56 Richardson C, Alessi DR. The regulation of salt transport and blood pressure by the WNK-SPAK/OSR1 signalling pathway. Journal of Cell Science 2008;121:3293-304. [DOI: 10.1242/jcs.029223] [Cited by in Crossref: 202] [Cited by in F6Publishing: 190] [Article Influence: 14.4] [Reference Citation Analysis]
57 Moes AD, van der Lubbe N, Zietse R, Loffing J, Hoorn EJ. The sodium chloride cotransporter SLC12A3: new roles in sodium, potassium, and blood pressure regulation. Pflugers Arch 2014;466:107-18. [PMID: 24310820 DOI: 10.1007/s00424-013-1407-9] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 5.7] [Reference Citation Analysis]
58 Subasinghe CJ, Sirisena ND, Herath C, Berge KE, Leren TP, Bulugahapitiya U, Dissanayake VHW. Novel mutation in the SLC12A3 gene in a Sri Lankan family with Gitelman syndrome & coexistent diabetes: a case report. BMC Nephrol. 2017;18:140. [PMID: 28446151 DOI: 10.1186/s12882-017-0563-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
59 Mercier-Zuber A, O'Shaughnessy KM. Role of SPAK and OSR1 signalling in the regulation of NaCl cotransporters. Curr Opin Nephrol Hypertens 2011;20:534-40. [PMID: 21610494 DOI: 10.1097/MNH.0b013e3283484b06] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
60 Lin S. A Practical and Pathophysiologic Approach to Hypokalemia. Hong Kong Journal of Nephrology 2008;10:14-26. [DOI: 10.1016/s1561-5413(08)60014-9] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
61 Wang T, Chen Y, Yin X, Qiu H. Novel heterozygous mutation of SLC12A3 gene in Gitelman syndrome. QJM 2021;114:513-5. [PMID: 33772578 DOI: 10.1093/qjmed/hcab066] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Lü Q, Zhang Y, Song C, An Z, Wei S, Huang J, Huang L, Tang L, Tong N. A novel SLC12A3 gene homozygous mutation of Gitelman syndrome in an Asian pedigree and literature review. J Endocrinol Invest 2016;39:333-40. [PMID: 26260218 DOI: 10.1007/s40618-015-0371-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
63 Larkins N, Wallis M, McGillivray B, Mammen C. A severe phenotype of Gitelman syndrome with increased prostaglandin excretion and favorable response to indomethacin. Clin Kidney J 2014;7:306-10. [PMID: 25852896 DOI: 10.1093/ckj/sfu029] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
64 Wu K, Cheng C, Sung C, Tseng M, Hsu Y, Yang S, Chau T, Lin S. Identification of the Causes for Chronic Hypokalemia: Importance of Urinary Sodium and Chloride Excretion. The American Journal of Medicine 2017;130:846-55. [DOI: 10.1016/j.amjmed.2017.01.023] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
65 Huang CL, Yang SS, Lin SH. Mechanism of regulation of renal ion transport by WNK kinases. Curr Opin Nephrol Hypertens 2008;17:519-25. [PMID: 18695394 DOI: 10.1097/MNH.0b013e32830dd580] [Cited by in Crossref: 53] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
66 Sung CC, Cheng CJ, Chiang WF, Chau T, Hsu YJ, Yang SS, Lin SH. Etiologic and therapeutic analysis in patients with hypokalemic nonperiodic paralysis. Am J Med 2015;128:289-96.e1. [PMID: 25447623 DOI: 10.1016/j.amjmed.2014.09.027] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
67 Wang L, Dong C, Xi YG, Su X. Thiazide-sensitive Na+-Cl- cotransporter: genetic polymorphisms and human diseases. Acta Biochim Biophys Sin (Shanghai) 2015;47:325-34. [PMID: 25841442 DOI: 10.1093/abbs/gmv020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
68 Acelajado MC, Culpepper RM, Bolton Iii WD. Hyperemesis Gravidarum in Undiagnosed Gitelman's Syndrome. Case Rep Med 2016;2016:2407607. [PMID: 27579038 DOI: 10.1155/2016/2407607] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
69 Ravarotto V, Loffing J, Loffing-Cueni D, Heidemeyer M, Pagnin E, Calò LA, Rossi GP. Gitelman's Syndrome: characterization of a novel c.1181G>A point mutation and functional classification of the known mutations. Hypertens Res 2018;41:578-88. [PMID: 29925901 DOI: 10.1038/s41440-018-0061-1] [Reference Citation Analysis]